Metacycline Market - Forecast(2024 - 2030)

Metacycline Market Overview

Metacycline Market size is estimated to reach $4,070 million by 2026, growing at a CAGR of 4.5% over 2021-2026. Metacycline is a kind of tetracycline antibiotics and has wide spectrum of antimicrobial action. It is used in the industrial synthesis of doxycycline hyclate and are active against most gram-positive bacteria. It also protects the binding of aminoacyl transfer RNA to the m-RNA-ribosome complex in the ribosome 30S subunit. Metacycline are also used for the treatment of bacterial exacerbations of chronic bronchitis and rickettsial infections. 

Metacycline acts as a tissue of the human pregnane X receptor ligand. Metacycline is administered orally and this antibiotic is available in various brand names such as Esarondil, physiomycine, lysocline, rotilen and many more. Growing number of rickettsial infections among people and growing development in the healthcare industry is the major factor driving the growth of this market. Furthermore, increasing research and development activities regarding drugs and rising geriatric population is set to further enhance the overall market demand for Metacycline Market for the period 2021-2026.

Metacycline Market Report Coverage

The report: “Metacycline Market Forecast (2021-2026)”, by IndustryARC, covers an in-depth analysis of the following segments of the Metacycline Market.   

By Therapeutics: Chronic Bronchitis, Rickettsial Infections, Pneumonia, Trench Fever, Typhus, Q Fever, and Others
By End-Use Industry: Hospitals, Clinics, and Others
By Geography: North America (U.S., Canada, Mexico), Europe (U.K, Germany, Italy, France, Spain, Russia, Rest of Europe), Asia Pacific (China, Australia, Japan, South Korea, India, Rest of Asia Pacific), South America (Brazil, Argentina, Others) and Rest of the World (Middle East, Africa)

Key Takeaways

• Geographically, in 2020, North America dominated the Metacycline Market owing to presence of advanced healthcare system and rising development in pharmaceutical industry.
• Growing number of rickettsial infections among people and growing development in the healthcare industry are likely to aid in the market growth of the Metacycline.
• Detailed analysis of the Strength, Weakness, and Opportunities of the prominent players operating in the market will be provided in the Metacycline Market report.  
• Increasing availability of substitute is set to create hurdles for the Metacycline Market.

Metacycline Segment Analysis – By Therapeutics

The global Metacycline Market based on Therapeutics can be further segmented into Chronic Bronchitis, Rickettsial Infections, Pneumonia, Trench Fever, Typhus, Q Fever, and Others. The chronic bronchitis segment is the major segment generating revenue in 2020. According to American Lung Association, in 2018 about 9 million people suffered from chronic bronchitis hat increased the demand of doxycycline hyclate and are rising the growth of this segment. The Rickettsial Infections segment is estimated to register the fastest CAGR of 0.75% for the period 2021-2026. Metacycline is considered as tetracycline antibiotics which is used for the treatment of rickettsial infections and are increasing the growth of this segment.

Metacycline Segment Analysis – By End-Use Industry

The global Metacycline Market based on End-Use Industry can be further segmented into Hospitals, Clinics, and Others. The Hospital segment registers for the Metacycline highest market share in 2020. This is owing to easy accessibility of hospital and higher selling capacity. Moreover, owing to availability of skilled professional patients can prefer hospitals and are rising the growth of this segment. The Clinics segment is estimated to register the fastest CAGR of 1.5% over 2021-2026. This is mainly owing to clinics that are opened for more time which increases the selling capacity and also provide fast service that increases the demand of metacycline and are increasing the growth of this market.

Metacycline Segment Analysis – By Geography

North America dominated the Metacycline Market with major share of 40% in 2020. This is owing to presence of advanced healthcare system and rising development in pharmaceutical industry. According to American Hospital Association, in 2019 about 6,090 hospitals are discovered that increases the development in healthcare system and are rising the growth of this segment. However, Asia Pacific is estimated to outpace all the regions by clocking the highest CAGR of 2.25% during the forecast period 2021-2026 owing to rising population and increasing development in healthcare.

Metacycline Market Drivers

Growing Number of Rickettsial Infections

Growing number of various diseases among people such as rickettsial, pneumonia, sinusitis, trench fever, and typhus increases the growth of the Metacycline Market. According to Center for Disease Control and Prevention, in 2018 about 1.3 million people in U.S. are suffered from pneumonia disease that increased the demand of metacycline and are increasing the growth of the Metacycline Market over 2021-2026.

Growing Development in the Healthcare Industry

Growing Development in the healthcare industry and rising adoption of advanced technology increases the growth of the Metacycline Market. Moreover, rising medical application in metacycline medication and growing innovative treatment in medical facilities can be attributed to the growth of Metacycline Market over 2021-2026.  

Covid-19 Impact:

COVID-19 pandemic had greatly affected the Metacycline Market. Owing to pandemic, hospitals are engaged for the treatment of patients with viral infections that hamper the growth of this market. Moreover, large number of beds are covered with the patients suffering from coronavirus disease and owing this doctors are not available for the treatment of other diseases and are negatively impacted the growth of this market.

Metacycline Market Challenges

Increasing Availability of Substitute

The factors that is set to impede the growth of the Metacycline Market are increasing availability of substitute such as miciclin, monatrex, and muvito. Moreover, stringent government approval is set to create hurdles for the Metacycline Market.

Metacycline Market Landscape

 Product launches, mergers and acquisitions, joint ventures, and geographical expansions are key strategies adopted by players in the Metacycline Market. Metacycline top 10 companies include, Merck, Boc Sciences, Manus Aktteva Biopharma LLP, Cayman Chemical, Hycultec GmbH, Abcam plc, Santa Cruz Biotechnology, Inc., Hlzel Biotech, Changzhou Pharmaceutical Factory, and The ND Pharma & Biotech Company.

Development

• In January 2021, Abcam has acquisition with Shuwen are working on the development of metacycline in order to reduce various disease and are rising the growth of this market.

Relevant Reports:

Pneumonia Testing Market

Report Code: HCR 30236

Report Code: HCR 11442

For more Lifesciences and Healthcare Market reports, please click here